The Neuroscience of Neurodiversity in Entrepreneurship

The paper's argument runs: the entrepreneurship literature on neurodiversity ignores neuroscience → therefore integrating neuroscience would be valuable. Both steps have structural problems.

The claim that there are "virtually no references" to neuroscience in this literature is asserted without any measurement procedure. The authors did not search their 27 papers' reference lists for neuroscience content, did not code papers for biological engagement, and did not define what counts as "engagement with neuroscience." Meanwhile, Nicolaou and colleagues (2011), in their 27-paper sample, is a candidate-gene study examining associations between a dopamine receptor gene and entrepreneurial tendency. That is a biological study of exactly the kind the authors say is missing. They list it in their summary table but never reconcile it with their claim.

Even granting the absence, the paper never shows that filling it would change any entrepreneurship prediction or intervention. Every neuroscience-to-entrepreneurship connection follows the same template: a brain region is involved in a cognitive function, that cognitive function matters for entrepreneurship, therefore the brain region is relevant. The prefrontal cortex is involved in virtually all complex cognition; this reasoning could connect any condition affecting it to any demanding activity.

The paper also reads its evidence selectively. The bipolar disorder section claims manic phases bring "heightened creativity" and "bold entrepreneurial decisions," but Johnson and colleagues (2015) — in the paper's reference list — found that manic tendencies were not related to being an entrepreneur, intending to become one, or succeeding as one. Johnson and colleagues (2018), also in the sample, calls the direct link "inconclusive." Neither contradiction is addressed. Several papers in the sample report that ADHD symptoms predict business failure, lower income, and impeded entrepreneurial behavior, but the conclusion frames neurodiversity primarily as "a driving force in organizations and a catalyst to drive innovation."

The paper's core concepts are too imprecise to do analytical work. "Neurodiversity" blends a descriptive claim (people vary neurologically) with a political commitment (society should accept that variation), and the paper never separates them. "Organizational neuroscience" is a field label, not an analytical concept — any study mentioning both a brain region and a business outcome would qualify. The neuroscience absence is never operationalized. The paper's framing of neurodiversity as "competitive advantage versus pathology" cannot accommodate the mixed findings in its sample, where the same ADHD symptoms predict both positive and negative outcomes depending on symptom dimension and outcome measure.

The neural-to-entrepreneurial "mapping" is unfalsifiable. Saying that prefrontal cortex differences in ADHD are relevant to entrepreneurship because the prefrontal cortex is involved in decision-making excludes nothing — you could substitute chess, surgery, or military command and reach the same conclusion with the same citations.

The absence motivating the paper is asserted rather than measured. The value of filling it is assumed rather than argued. The strongest counterargument — that behavioral measurement already captures everything entrepreneurship researchers need, making neural-level data unnecessary — is never raised.

The paper treats neuroscience explanation as inherently more valuable than behavioral explanation without stating this premise, let alone defending it. The bibliometric analysis is solid as a counting exercise but overgeneralized: claiming conditions like autism are "entirely overlooked" in entrepreneurship research conflates "not studied in A-ranked journals indexed in one database" with "not studied." The Lotka's Law finding (72 of 79 authors published only one paper) is presented as evidence of fragmentation, but any 27-paper literature with typical co-authorship rates will produce this pattern regardless of the field's actual structure.

The paper's central premise — that entrepreneurship needs neuroscience — is assumed rather than argued, and the essential steps connecting clinical neuroscience findings to entrepreneurship predictions are never made explicit. Three major inferential jumps are untraceable: from "absence exists" to "absence matters," from clinical neuroscience to entrepreneurial outcomes, and from a 27-paper sample of top-tier journals to claims about an entire research field.

The paper contains findings that directly undercut its framing without reconciling them. Johnson and colleagues (2015) found no relationship between manic tendencies and entrepreneurship; Nicolaou and colleagues (2011) conducted a biological study of entrepreneurship that contradicts the "virtually no engagement" claim. Both appear in the paper's tables but are not integrated into its argument.

No conflict-of-interest statement is included despite one co-author's commercial affiliation (discussed under independence).

The citation practices are unreliable in the paper's most consequential sections.

Thurik and colleagues (2016) is cited as evidence that ADHD relates to entrepreneurial orientation, but that paper was retracted. The reference list includes the word "Retracted" in the title, yet the main text treats it as valid evidence.

In the bipolar disorder section, MacQueen and colleagues (2008) is cited to support reduced hippocampal volume in bipolar disorder, but that paper studied major depressive disorder, not bipolar disorder. Robinson and colleagues (2006) is cited to support claims about brain activity during manic and depressive episodes, but that paper is a meta-analysis of cognitive deficits in patients between episodes — during their stable phase. These are misattributions to the wrong condition or patient state.

The recommendations section cites five papers authored or co-authored by Massaro, one of this paper's co-authors. The proposed future methods — heart-rate variability monitoring, neurofeedback, wearable devices — route disproportionately through this single research group's output. Alternative methodological sources are not presented.

Co-author Massaro lists both the University of Surrey and "Organizational Neuroscience Ltd, UK" — a company he founded — as affiliations. The paper's central recommendation is that entrepreneurship research should integrate "organizational neuroscience." The recommendation and the co-author's commercial identity share the same three words.

The paper's methodological proposals cite Massaro's prior publications as the relevant authority. The introduction credits entrepreneurship research with helping establish organizational neuroscience as a field, citing Massaro's work. No conflict-of-interest disclosure accompanies any of this. The absence motivating the paper was asserted without measurement, and a stricter analysis would have risked finding it smaller than stated, weakening the case for organizational neuroscience as the remedy.